S-1/A: Presurance Holdings Launches $14M Rights Offering

Presurance Holdings, Inc. is conducting a non-transferable subscription rights offering to raise up to $14 million by issuing 14,000,000 shares of common stock at $1.00 per share.

Summary

• Presurance Holdings, Inc. (PRHI) is conducting a non-transferable subscription rights offering to raise up to $14.0 million in gross proceeds.
• Shareholders of record as of February 6, 2026, at 5:00 p.m. New York City time, will receive one subscription right for each common stock share owned.
• Each subscription right entitles the holder to purchase 1.145 shares of common stock at a subscription price of $1.00 per share.
• The rights offering will expire on February 24, 2026, at 5:00 p.m. New York City time, unless extended.
• The net proceeds are intended for the repurchase or redemption of all or a portion of Series B Preferred Stock and for general corporate purposes.
• Clarkston Companies, Inc., an entity affiliated with a board member, has entered into a backstop agreement to purchase any unsubscribed shares, ensuring the full $14.0 million is raised.
• The company's common stock trades on the Nasdaq Capital Market under the symbol PRHI, with a closing price of $0.72 per share on February 2, 2026, and $0.65 per share on January 13, 2026.
• The board of directors makes no recommendation regarding the exercise of subscription rights.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing negatively due to significant adverse developments in loss reserves and reinsurance recoverables, coupled with a dilutive rights offering priced above the current market, primarily backstopped by an already influential related party. While the capital raise addresses immediate liquidity needs, the underlying operational and financial challenges remain concerning.

Positives

• Secures up to $14.0 million in gross proceeds, supported by a backstop agreement, ensuring the capital raise objective is met.
• Intends to use proceeds to repurchase or redeem Series B Preferred Stock, which could reduce debt service costs and improve the capital structure.
• Provides existing shareholders an opportunity to maintain their proportionate ownership and participate in the capital raise.

Negatives

• Significant dilution for shareholders who do not fully exercise their subscription rights, as up to 14,000,000 new shares will be issued, nearly doubling the outstanding shares from 12,222,881.
• The subscription price of $1.00 per share is higher than the recent market prices ($0.72 on February 2, 2026, and $0.65 on January 13, 2026), meaning investors exercising rights will pay a premium to the current market price.
• Subscription rights are non-transferable, preventing shareholders from selling them for value if they choose not to exercise.
• All exercises of subscription rights are irrevocable, exposing investors to potential losses if the market price declines further after exercise.
• The company's board of directors makes no recommendation regarding the exercise of subscription rights, placing the full burden of the investment decision on shareholders.
• The company expects to increase reserve estimates for additional adverse development of up to potentially $5.0 million at December 31, 2025, for loss years prior to 2025.
• A reinsurer providing a loss portfolio transfer (LPT) failed to fund a $4.4 million collateral shortfall in December 2025, and joint provisional liquidators were appointed, making it likely the company will need to write off $2.0 million to $4.4 million of LPT recoverables.
• Only $1.6 million of unused coverage remains on the LPT as of September 30, 2025, and no additional recoveries are expected under the LPT due to the reinsurer's financial condition.
• The company may not receive $6.3 million in contingent consideration from the August 2024 sale of CIS, which would reduce anticipated future liquidity and shareholders' equity.
• If the rights offering is not completed, the company may not be able to pay off the $7.5 million liquidation preference on the Series B Preferred Stock due by December 31, 2026.
• The rights offering could impair or limit net operating loss (NOL) carryforwards of approximately $65 million due to a potential ownership change.
• Clarkston Ventures, LLC and its affiliates, already significant shareholders (30.6% common stock, 42.1% voting power including Series B Preferred), will increase their beneficial ownership and influence through the backstop agreement, potentially conflicting with other shareholders' interests.

Risks

• Actual incurred losses may be greater than loss and loss adjustment expense reserves, which could materially adversely affect financial condition and results of operations.
• Underestimation of claims costs due to variables like actuarial projections, claims handling procedures, inflation, severe weather, climate change, economic and judicial trends, and legislative changes.
• Uncertainty in establishing loss reserves, including long claim development periods, increasing loss estimates over time, new theories of liability, and volatility in financial markets.
• Anticipated reinsurance recoverables on reserves could be negatively impacted by contractual limits of coverage, such as the $20.0 million limit on the loss portfolio transfer (LPT), with $18.4 million already utilized and only $1.6 million remaining as of September 30, 2025.
• Failure of a reinsurer to fund a $4.4 million collateral shortfall in December 2025, and the appointment of joint provisional liquidators, making it likely the company will write off $2.0 million to $4.4 million of LPT recoverables.
• No additional recoveries expected under the LPT for adverse development in accident years 2019 and prior due to the reinsurer's financial condition.
• Preliminary assessment indicates an expected increase in reserve estimates for additional adverse development of up to potentially $5.0 million at December 31, 2025.
• Part of the gain on the sale of CIS is $6.3 million of contingent consideration that may not be received, reducing anticipated future liquidity, assets, and shareholders' equity.
• If the rights offering is not completed, the company may need other sources of liquidity to repay the $7.5 million liquidation preference on the Series B Preferred Stock due by December 31, 2026.
• The market price of common stock is volatile and may decline before or after subscription rights expire, leading to immediate unrealized losses for purchasers.
• Inability to sell shares purchased in the rights offering at or above the subscription price.
• Dilution of ownership interest for shareholders who do not fully exercise their subscription rights.
• Subscription rights are non-transferable, meaning no market exists to realize their value without exercising them.
• The subscription price of $1.00 per share is not necessarily an indication of the fair value of the common stock and may not be sustained in the market.
• Management has broad discretion over the use of proceeds, and investments may not yield a favorable return.
• The company may cancel or amend the rights offering at any time, with limited recourse for subscribers.
• Uncertainty regarding the consummation of the backstop agreement transaction, which could impact capital availability.
• Irrevocability of subscription exercises, even if unfavorable information emerges or the offering is extended (unless fundamental changes or extensions over 30 days occur).
• Risk of purchasing shares above the prevailing market price if the stock price declines after exercising rights.
• Rejection of subscription exercises if instructions are not followed promptly and precisely.
• Uncertain tax treatment of the rights offering, potentially being deemed a taxable event if considered a disproportionate distribution.
• The rights offering could impair or limit net operating loss (NOL) carryforwards (approximately $65 million as of December 31, 2024) due to a potential ownership change.
• The rights offering may cause the price of common stock to decrease due to the announcement and potential for future sales by exercising shareholders.
• No interest will be paid on subscription funds, even if returned.
• Clarkston Ventures, LLC and its affiliates have significant influence (30.6% common stock, 42.1% voting power) and their ownership will increase, potentially leading to differing interests from other shareholders.
• The company has never paid dividends and does not anticipate doing so in the foreseeable future.
• Future sales or other dilution of equity could adversely affect the market price of common stock.
• Provisions in articles of incorporation, bylaws, and Michigan law (e.g., classified Board, limitations on shareholder action, preferred stock issuance) could make it more difficult for a third party to acquire the company or change management.

Future Outlook

The company intends to use the net proceeds from the rights offering to repurchase or redeem all or a portion of its Series B Preferred Stock and for general corporate purposes, aiming to strengthen its financial condition and provide sufficient liquidity through December 31, 2026. However, it anticipates increasing reserve estimates for adverse development by up to $5.0 million at December 31, 2025, and expects to write off $2.0 million to $4.4 million of LPT recoverables due to a reinsurer's financial distress. The company does not anticipate paying dividends on its common stock in the foreseeable future, intending to retain earnings for growth.

Management Comments

• "Our board of directors is making no recommendation regarding your exercise of the subscription rights."
• "You are urged to make your decision based on your own assessment of our business and the rights offering."
• "We believe, and intend to take the position, that the rights offering should not be part of a disproportionate distribution of our stock, but certain aspects of that determination are unclear."
• "Our objective is to raise the full $14.0 million in gross proceeds from our rights offering."
• "We have therefore obtained a commitment from the Backstop Purchasers in order to establish a higher likelihood of receiving the full amount of our rights offering objective."
• "We currently intend to retain earnings, if any, to support our growth strategy. We do not anticipate paying dividends on our common stock in the foreseeable future."

Industry Context

StockSavvy.ai notes that the rights offering by Presurance Holdings, an insurer transitioning from an MGA model back to underwriting, highlights the capital-intensive nature of the insurance industry, particularly for companies facing adverse loss reserve development and reinsurer defaults. The move to recapitalize and address preferred stock obligations is a common strategy for smaller or niche insurers seeking to stabilize their balance sheets amidst market pressures and regulatory scrutiny. The significant insider participation via the backstop agreement, while ensuring the capital raise, also raises questions about corporate control and potential conflicts of interest, a trend often observed in smaller cap companies undergoing financial restructuring.

Comparison to Industry Standards

• The subscription price of $1.00 per share, compared to recent market prices of $0.72 and $0.65, is unusual for a rights offering where the price is typically set at a discount to encourage participation. This suggests a strong need for capital or a valuation disconnect.
• The expected increase in loss reserves of up to $5.0 million and the potential write-off of $2.0 million to $4.4 million in reinsurance recoverables due to reinsurer insolvency are significant for a company of this size and indicate challenges in underwriting and risk transfer, potentially below industry best practices for reserve adequacy and counterparty risk management.
• The high dividend rates on preferred stock (13.0% for Series B, 15.0% for Series C) suggest a high cost of capital, likely reflecting perceived risk by investors, which is higher than typical investment-grade corporate bond yields or preferred stock dividends for more stable insurers.
• The substantial beneficial ownership and increasing influence of Clarkston Ventures, LLC and its affiliates (42.1% voting power post-offering) is higher than average for publicly traded companies, potentially impacting corporate governance and alignment with minority shareholders.

Corporate Governance

Related Party Transactions

• On December 23, 2025, the company sold 1,600 shares of Series C Preferred Stock for $8.0 million to Clarkston Companies, Inc., an entity affiliated with Jeffrey Hakala, a member of the Board of Directors.
• Clarkston Companies, Inc. and certain of its affiliates (the Backstop Purchasers) entered into a Rights Offering Backstop Agreement on February 3, 2026, committing to exercise their own rights in full and purchase any unsubscribed shares in the rights offering. Jeffrey Hakala is the Chief Executive Officer of Clarkston Companies, Inc.
• The Backstop Purchasers may fund a portion of their purchase price by offsetting amounts payable by the company for the repurchase or redemption of Series B Preferred Stock.
• On February 27, 2025, and March 3, 2025, the company issued a total of $7.5 million of Series B Preferred Stock and warrants to Clarkston 91 West LLC, an entity affiliated with Gerald and Jeffrey Hakala, both board members at the time. The Series B Preferred Stock was subsequently sold to Clarkston Companies, Inc.
• As of February 2, 2026, Clarkston Ventures, LLC and its affiliates beneficially owned approximately 30.6% of outstanding common stock and, together with Series B Preferred Stock voting rights, held 42.1% of outstanding voting shares. Gerald Hakala and Jeffrey Hakala are Co-Chief Investment Officers of Clarkston Ventures, LLC.

Stakeholder Impact

• Shareholders who do not exercise their rights will experience significant dilution of their ownership percentage. Those who exercise will pay a premium to the current market price but will maintain their proportionate ownership and potentially benefit from the capital raise. All shareholders face risks related to the volatile stock price and potential decline after the offering.
• Creditors may benefit from the improved debt structure and enhanced liquidity if the proceeds are used to repurchase or redeem Series B Preferred Stock, potentially strengthening the company's ability to meet future obligations.
• Management and the Board gain necessary liquidity and address a key financial obligation (Series B Preferred Stock). The backstop agreement reduces financial uncertainty for management, but the increased influence of Clarkston affiliates could impact future strategic decisions.
• Employees are not directly impacted by this filing, but a stronger financial position could provide more stability for the company's operations.

Next Steps

• Commence and complete the rights offering as soon as reasonably practicable.
• Cause the Registration Statement to be declared effective by the SEC as soon as reasonably practicable.
• Distribute subscription rights to holders of common stock as of the record date (February 6, 2026).
• Shareholders to exercise subscription rights by February 24, 2026, at 5:00 p.m. New York City time.
• Company to issue a press release if the rights offering expiration is extended.
• Company to issue a press release if the rights offering is cancelled.
• Company to file a post-effective amendment and recirculate an updated prospectus if fundamental changes are made to the rights offering terms.
• Company to issue a press release announcing any changes to the rights offering and new expiration date if amended.
• Subscription agent to return excess subscription payments without interest as soon as practicable after completion of the rights offering.
• Company to issue new shares as soon as practicable after the closing of the rights offering.
• Company to file its Annual Report on Form 10-K in March 2026, which will include December 31, 2025 financial statements and actuarial analysis.
• The next reserve analysis by an opining actuary will be for the reserve position as of December 31, 2025.
• Repurchase or redemption of Series B Preferred Stock with proceeds from the rights offering.

Key Dates

Recommendation

The filing reveals significant financial distress, including expected increases in loss reserves and a substantial write-off of reinsurance recoverables due to a reinsurer's insolvency. While the rights offering aims to raise capital, it is priced significantly above the current market price, making it immediately dilutive and unfavorable for existing shareholders who participate. Non-participating shareholders face substantial dilution. The heavy reliance on a related party for the backstop commitment, coupled with their already significant and increasing control, raises corporate governance concerns. Given these adverse financial indicators, the dilutive nature of the offering, and the premium pricing relative to market, a seasoned investor would likely recommend selling to avoid further potential losses and to exit a company facing considerable operational and financial headwinds.

Keywords

Presurance Holdings, PRHI, Rights Offering, Common Stock, Capital Raise, SEC Filing, S-1/A, Subscription Rights, Dilution, Backstop Agreement, Clarkston Companies, Insurance, Specialty Insurance, Property & Casualty, Loss Reserves, Reinsurance, Preferred Stock, Corporate Governance, Nasdaq Capital Market